CN112522349A - Microbial flocculant for clarifying brewed vinegar and preparation method and application thereof - Google Patents
Microbial flocculant for clarifying brewed vinegar and preparation method and application thereof Download PDFInfo
- Publication number
- CN112522349A CN112522349A CN202011518642.2A CN202011518642A CN112522349A CN 112522349 A CN112522349 A CN 112522349A CN 202011518642 A CN202011518642 A CN 202011518642A CN 112522349 A CN112522349 A CN 112522349A
- Authority
- CN
- China
- Prior art keywords
- culture
- microbial flocculant
- vinegar
- fermentation
- clarifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000052 vinegar Substances 0.000 title claims abstract description 45
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 45
- 230000000813 microbial effect Effects 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 31
- 238000000855 fermentation Methods 0.000 claims abstract description 27
- 230000004151 fermentation Effects 0.000 claims abstract description 27
- 238000012360 testing method Methods 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000011218 seed culture Methods 0.000 claims abstract description 14
- 241001070941 Castanea Species 0.000 claims abstract description 10
- 235000014036 Castanea Nutrition 0.000 claims abstract description 10
- 239000001963 growth medium Substances 0.000 claims abstract description 9
- 241000179039 Paenibacillus Species 0.000 claims abstract description 8
- 230000004913 activation Effects 0.000 claims abstract description 8
- 230000001580 bacterial effect Effects 0.000 claims abstract description 7
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 6
- 239000000725 suspension Substances 0.000 claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims abstract description 4
- 239000008223 sterile water Substances 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 18
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 18
- 239000002609 medium Substances 0.000 claims description 10
- 239000001888 Peptone Substances 0.000 claims description 9
- 108010080698 Peptones Proteins 0.000 claims description 9
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 9
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 9
- 235000019319 peptone Nutrition 0.000 claims description 9
- 239000001103 potassium chloride Substances 0.000 claims description 9
- 235000011164 potassium chloride Nutrition 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims description 6
- 229960004793 sucrose Drugs 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 238000012136 culture method Methods 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000008274 jelly Substances 0.000 claims description 3
- 235000010344 sodium nitrate Nutrition 0.000 claims description 3
- 239000004317 sodium nitrate Substances 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 238000002834 transmittance Methods 0.000 abstract description 11
- 238000005352 clarification Methods 0.000 abstract description 9
- 150000004676 glycans Chemical class 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- 238000005189 flocculation Methods 0.000 description 32
- 230000016615 flocculation Effects 0.000 description 31
- 230000000694 effects Effects 0.000 description 23
- 241000699670 Mus sp. Species 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 239000008394 flocculating agent Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 238000005259 measurement Methods 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 208000031404 Chromosome Aberrations Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 241000209094 Oryza Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 231100000005 chromosome aberration Toxicity 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000013256 coordination polymer Substances 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 3
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000005534 hematocrit Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010050208 Teratospermia Diseases 0.000 description 2
- 208000002312 Teratozoospermia Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- 238000010256 biochemical assay Methods 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000000918 epididymis Anatomy 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000031864 metaphase Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000009666 routine test Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 238000004065 wastewater treatment Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 159000000013 aluminium salts Chemical class 0.000 description 1
- 239000001164 aluminium sulphate Substances 0.000 description 1
- 235000011128 aluminium sulphate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- BUACSMWVFUNQET-UHFFFAOYSA-H dialuminum;trisulfate;hydrate Chemical compound O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BUACSMWVFUNQET-UHFFFAOYSA-H 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013214 routine measurement Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 210000004888 thoracic abdominal cavity Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Abstract
A microbial flocculant for clarifying brewed vinegar and a preparation method and application thereof belong to the technical field of microbial engineering. The method comprises the following steps: 1) inoculating Paenibacillus chestnuts to a test tube slant culture medium for activation, washing with sterile water to obtain a bacterial suspension, inoculating for seed culture, and performing microscopic examination to obtain no mixed bacteria for later use; 2) performing fermentation culture in a fermentation tank to obtain a culture solution; 3) extracting and purifying to obtain the microbial flocculant. The microbial flocculant prepared by the method can be applied to clarifying and brewing table vinegar. The microbial flocculant produced by the method has good edible safety and a wide pH application range, the extracellular polysaccharide content in the fermentation culture solution prepared by the method is more than 3.57 percent, the mucopolysaccharide content accounts for more than 90 percent, the light transmittance of the vinegar can be increased by 240.63 percent, and the microbial flocculant can be applied to clarification of brewed vinegar.
Description
Technical Field
The invention belongs to the technical field of microbial engineering, and particularly relates to a microbial flocculant for clarifying brewed vinegar, and a preparation method and application thereof.
Background
The flocculant is widely applied to industrial processes such as wastewater treatment, drinking water purification, food and fermentation processing. Flocculants can be divided into inorganic flocculants such as aluminium salts (aluminium sulphate and polyaluminium chloride)) Chemical synthetic flocculants (derivatives of polyacrylamide and polyethylene) and biological flocculants. Among these flocculants, organic synthetic polymeric flocculants are widely used in practical production because of their good flocculation effect and low cost. Polyacrylamide is a common one, but has difficult degradability, and evidence shows that acrylamide monomers are strong carcinogens and have strong neurotoxicity, and the acrylamide monomers remaining in the environment are easy to cause secondary pollution. Many countries currently ban or restrict the use of such flocculants. The use of inorganic flocculant can bring a large amount of inorganic ions into treatment liquid in food and fermentation industries, and the excessive inorganic ions not only influence the flavor and taste of products, but also are not beneficial to human health, especially Al3+Has a direct relationship with the increasing initiation of the senile dementia at present; fe3+Has strong corrosivity and easy residue, and can make the water band to be treated have color and influence the water quality. Becomes a new problem for disposal, regeneration and reuse. Although natural polymeric flocculants such as chitosan, sodium alginate and chitin in the biological flocculant are nontoxic and can be safely degraded, the flocculation activity is weak, the cost is high, and the wide application of the biological flocculant is limited. The microbial flocculant is a special high-molecular polymer which is produced by microorganisms in the growth process and can cause aggregation and precipitation of solid suspended particles, thallus cells, colloid particles and the like which are not easy to degrade in a water body. The flocculant is easy to separate, high in settling efficiency, degradable, nontoxic and harmless to the environment as a degradation product, free of secondary pollution, wide in application range, good in turbidity removal and decoloration effects, and efficient and environment-friendly. Because the growth speed of the microorganism is high, industrialization is easy to realize by adopting methods such as fermentation engineering and the like. Accordingly, bioflocculants derived from microorganisms are receiving increasing attention. Microbial flocculants are expected to be applied more and more in various fields as a promising substitute of chemical flocculants.
Vinegar has been widely used as an acidic condiment throughout the world for thousands of years. They are rich in nutrients and bioactive compounds, including amino acids, sugars, organic acids, polyphenols, melanin, and tetramethylpyrazine. These functional compounds not only can increase the flavor of vinegar, but also play an important role in preventing and treating human diseases, such as regulating blood lipid level, reducing weight, resisting fatigue, resisting tumor, etc. In the whole brewing process of the vinegar, because macromolecular substances such as starch, cellulose, protein, fat and the like in the raw materials are not thoroughly decomposed, the vinegar is turbid, precipitates are formed, and the quality of the vinegar is influenced, the vinegar is clarified before leaving the factory, otherwise, the components are gradually aggregated and form precipitates again in the storage process. At present, the clarification method of vinegar mainly comprises a flocculation method, a membrane filtration method and an enzyme clarification method. Among these methods, the flocculation method is widely used because of its simple process and low cost. In the clarification process of vinegar, many flocculants are reported, such as bentonite, chitosan, egg white and the like. However, the application and research of the microbial flocculant in vinegar clarification are not reported.
Disclosure of Invention
Aiming at the problems in the prior art, the invention aims to design and provide a fermentation process of a bacterial strain for producing biological flocculant with high yield, and apply the fermentation process to clarification process treatment in the actual vinegar production process. The microbial flocculant is prepared by chestnut tree paenibacillus slant culture, primary seed culture, fermentation culture solution preparation, CPC complexation-alcohol precipitation extraction and purification, and is applied to vinegar clarification treatment process.
A preparation method of a microbial flocculant for clarifying brewed vinegar is characterized by comprising the following steps:
1) inoculating Paenibacillus chestnuts to a test tube slant culture medium for activation, washing with sterile water after activation to obtain bacterial suspension, inoculating to a triangular flask containing a seed culture solution for seed culture, and performing microscopic examination to obtain no mixed bacteria for later use;
2) putting the fermentation medium into a fermentation tank, carrying out autoclaving at 121 ℃ for 20 minutes, then inoculating the seeds obtained in the step 1), and carrying out fermentation culture to obtain a culture solution;
3) extracting and purifying the culture solution obtained in the step 2) to obtain the microbial flocculant.
The preparation method of the microbial flocculant for clarifying brewed vinegar is characterized in that a slant culture medium in the step 1) comprises the following components: 2.0% of soluble starch, 0.5% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate, 0.05% of magnesium sulfate and 2.0% of agar, and the activation culture method comprises the following steps: adjusting pH to 7.0, autoclaving test tube with slant culture medium at 121 deg.C for 20 min, inoculating Paenibacillus chestnut, and culturing at 28 deg.C for 48 hr.
The preparation method of the microbial flocculant for clarifying brewed vinegar is characterized in that the seed culture solution in the step 1) comprises the following components: 1.0% of soluble starch, 1.5% of sucrose, 0.5% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate and 0.05% of magnesium sulfate, and the seed culture method comprises the following steps: the triangular flask containing the seed culture solution was autoclaved at 121 ℃ for 20 minutes, and then the bacterial suspension was inoculated and cultured at 28 ℃ for 30 hours.
The preparation method of the microbial flocculant for clarifying brewed vinegar is characterized in that a fermentation medium in the step 2) comprises the following components: 3.0% of glucose, 0.1% of sodium nitrate, 0.3% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate and 0.05% of magnesium sulfate.
The preparation method of the microbial flocculant for clarifying brewed vinegar is characterized in that the fermentation culture method in the step 2) is as follows: the culture temperature is 28 ℃, the ventilation rate is 1VVM, the initial pH is 7.0, the initial stirring rotation speed is 300 r/min, the later stirring rotation speed is linked with dissolved oxygen, the lowest dissolved oxygen is controlled to be 20%, the culture time is 36 hours, the OD600 is more than 2.5, 3.0% (W/V) of cane sugar in the total volume of the fermentation liquid is added, the mixture is uniformly stirred, the mixture is placed in a culture dish, the liquid depth is controlled not to exceed 2.5cm, the culture is continued for 24 hours at 26 ℃, until the culture liquid is in a jelly shape, the charging amount of the fermentation tank is 70%, and the inoculation amount is 3.0%.
The preparation method of the microbial flocculant for clarifying brewed vinegar is characterized in that the microbial flocculant mainly comprises mucopolysaccharide, and the molecular structure of the microbial flocculant contains glucosamine and uronic acid.
The microbial flocculant obtained by the preparation method.
The microbial flocculant is applied to clarifying and brewing vinegar.
The application is characterized in that the application specifically comprises the following steps: heating brewed edible vinegar to 41.5 deg.C, adding CaCl2To a final concentration of 0.32mM, and then microbial flocculant was added to a final concentration of 3.94 mg/L.
The method provided by the invention is novel and easy to operate, and the produced microbial flocculant has good edible safety and a wide pH application range, is applicable to the pH range of 2.0-9.0, and has important practical value in industrial processes such as brewing food of table vinegar and the like, drinking water purification, wastewater treatment and the like. The fermentation culture solution prepared by the method has the extracellular polysaccharide content of more than 3.57 percent and the mucopolysaccharide content of more than 90 percent, can increase the light transmittance (lambda is 900nm) of rice vinegar by more than 240.63 percent, and can be applied to clarification of brewed vinegar (pH2.9-3.5).
Drawings
FIG. 1 is a graph of the effect of microbial flocculant dosage on the rate of increase in permeability;
FIG. 2 is a graph of the effect of flocculation system temperature on the rate of increase of permeability;
FIG. 3 is a graph showing the effect of metal ions on the rate of increase in transmittance;
FIG. 4 shows Ca2+Influence on the rate of increase of transmittance.
Detailed Description
The present invention will be further illustrated by the following examples.
Example 1:
before inoculation of the chestnut tree bacillus (Paenibacillus castanea), activation is firstly carried out on a test tube slant, the chestnut tree bacillus (Paenibacillus castanea) is cultured for 48 hours at the temperature of 28 ℃, and a slant culture medium used for culture comprises the following components: 2.0% of soluble starch, 0.5% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate, 0.05% of magnesium sulfate, 2.0% of agar and pH 7.0; then, the bacterial cells were washed with sterile water and inoculated into a flask (500mL) containing 100mL of a seed culture medium (1.0% soluble starch, 1.5% sucrose, 0.5% peptone, 0.05% potassium chloride, 0.1% dipotassium hydrogen phosphate, and 0.05% magnesium sulfate) to perform seed culture (30 hours at 28 ℃ C.). After the seeds are grown, microscopic examination is carried out to ensure that no mixed bacteria exist for standby.
A7L fermentation medium is prepared, and the formula of the medium comprises 3.0% of glucose, 0.1% of sodium nitrate, 0.3% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate and 0.05% of magnesium sulfate. The mixture was placed in a 10L fermenter, autoclaved at 121 ℃ for 20 minutes, and 200mL of cultured Erlenmeyer flask seeds were inoculated. The initial pH of the medium was adjusted to 7.0. Controlling culture conditions: the temperature is 28 ℃, the ventilation rate is 1VVM, the pH is controlled to be 7.0, the initial stirring speed is 300 r/min, the later stirring speed is linked with dissolved oxygen, the lowest dissolved oxygen is controlled to be 20%, the culture time is 36 hours until the OD600 is above 2.5, 3% of sucrose (W/V) of the total volume of the fermentation liquor is added and uniformly stirred, the culture is placed in a pot to a culture dish, the liquid depth is controlled not to exceed 2.5cm, and the culture is continued for 24 hours at 26 ℃ until the culture solution is in a jelly shape.
And collecting the culture solution, adding 3-fold water for dilution, filtering by using filter cloth, and removing somatic cells. Cetyl Pyridinium Chloride (CPC) was added at 2.0% (w/v) until no more insoluble CPC-bioflocculant complex formed. And adding 0.6mol/L NaCl brine into the precipitate until the precipitate is completely dissolved, adding 3 times of ethanol by volume, carrying out ethanol precipitation for 6 hours, removing supernatant, and freeze-drying the ethanol precipitate to obtain the purified microbial flocculant.
The application method of microbial flocculant in vinegar clarifying treatment process comprises heating vinegar to 41.5 deg.C, and adding CaCl with final concentration of 0.32mM2And then adding the mixture to a microbial flocculant with a final concentration of 3.94 mg/L. Under these conditions, the light transmittance (λ 900nm) of vinegar can be increased by 240.63% or more.
Example 2: optimization of application conditions of microbial flocculant in vinegar brewing
1. Method for measuring flocculation effect of vinegar
Collecting deep liquid fermentation vinegar, and taking the transmittance as an index for measuring the flocculation effect of the purified biological flocculant in the rice vinegar. 1mL of the purified bioflocculant solution was added to 100mL of rice vinegar. Stirring for 2min, standing for 10min, and collecting supernatant for analysis. The transmittance of the supernatant was measured at a wavelength of 900 nm. The control group was prepared in the same manner except that the sample solution was used instead of distilled water.
The rate of Increase of transmittance (IRT) was calculated as follows:
a is an initial value; b: post-flocculation treatment value
2. Single-factor optimization method for flocculation conditions of vinegar
2.1 Effect of the amount of microbial flocculant added on the flocculation Effect
The effect of the microbial flocculant on the vinegar transmittance increase rate is examined within the range of 1-11 mg/L, and the result is shown in figure 1.
As shown in figure 1, the IRT of the microbial flocculant in the addition range of 1-11 mg/L exceeds 48%, and when the optimal addition of the microbial flocculant is 3.0mg/L, the maximum IRT reaches 133.62%. When the bioflocculant is insufficient, the microbial flocculant bridging phenomenon cannot be effectively formed. Conversely, too much negatively charged bioflocculant will cause repulsion of the negatively charged particles, which will also reduce the effective volume, resulting in poor stability. This is consistent with the microbial mucopolysaccharide flocculant properties.
2.2 influence of flocculation System temperature on flocculation Effect
The effect of flocculation system temperature on flocculation effect is shown in figure 2. The flocculation activity gradually increases with increasing temperature, reaches a maximum at 40 ℃ and then gradually decreases. This may be due to the high temperature changing the spatial structure of the bioflocculant, resulting in a decrease in flocculation efficiency.
2.3 Effect of Metal ion type and concentration on flocculation Effect
To achieve higher flocculation activity, metal cations are often added during flocculation to enhance bridging and neutralization flocculation of the flocculant. The effect of cationic species on flocculation is shown in FIG. 3, Ca2+The effect of concentration on the flocculation effect is shown in figure 4.
As shown in FIG. 3, trivalent ions (Al)3+And Fe3+) Anddivalent ion (Ca)2+、Mg2+And Fe2+) Monovalent ion (Na)+And K+) Is more effective. Considering high cost and other considerations (Fe)2+Easily oxidized and colored system, Al3+Easily causing alzheimer disease), Ca2+Is an ideal coagulant aid. As can be seen from FIG. 4, when Ca is used2+The flocculation efficiency is higher when the concentration is 0.3 mM.
Box-Behnken design for further optimizing vinegar flocculation conditions
These factors were further optimized using the Box-Behnken design based on a single factor experiment. The test was performed in triplicate, with the average IRT at each run as the response variable. And analyzing the data acquired by the RSM according to a quadratic polynomial equation by adopting Design-Expert 10.0 software. The test results and the analysis of variance are shown in tables 1 and 2, respectively.
TABLE 1 Box-Behnken design and measurements thereof
TABLE 2 analysis of flocculation Condition variance
The adding amount of the biological flocculant, the temperature of a flocculation system and calcium chloride are important factors influencing the flocculation effect. The Box-Behnken design optimizes these factors with the average IRT as the response variable. The actual response value obtained by the analysis of variance is compared with the predicted response value, and the result shows that the model probability P (Pmodel 0.0009) has statistical significance and is very reliable for predicting the flocculation efficiency. The absence of fitted values was not significant (p-0.1292), and the flocculation efficiency was well predicted. Determining the coefficient (R)20.9504) represents the sufficiency of the model, accounting for 95.04% of the response variability. The optimal conditions for bioflocculants were obtained using the "numerical optimization" function in Design-Expert 10.0. When the flocculating agent is 3.94mg/L, CaCl2Is 032mM, the maximum increase in light transmittance at 41.5 ℃ of the flocculation system is 241.04%. To verify the reproducibility of the model, all experiments were performed under optimal conditions. The results showed that the transmittance was improved by 240.63%, 242.51%, and 243.64%, respectively. The model can reasonably optimize the flocculation condition of the rice vinegar and predict the flocculation efficiency of the rice vinegar clarification.
Example 3: safety test of products prepared by the method of the invention
1. Acute oral toxicity test in mice
Uniformly dispersing the prepared sample homogenizer in distilled water of 70 ℃ to prepare the solution with the concentration of 0.1 g/ml-1The solution was cooled to 40 ℃ for further use. Selecting clean-grade ICR mice with weight of 18-24g, 10 male and female respectively, fasting for 16h before gavage, and feeding the test object for 24h after weighing by gavage for three times, wherein the gavage volume is 40 ml/kg-1The total dosage is 12 g/kg-1. The food is fed 4h after the gavage, and the poisoning and death conditions are recorded after continuously observing for 14 d.
TABLE 3 record of weight gain in acutely toxic mice
Note: significant difference from the control group (P <0.05) and significant difference from the control group (P <0.01)
The appearance hair color of the mice is bright after administration, and the phenomena of excitation, uneasiness, drunkenness, jumping, hair erection, lacrimation, salivation, convex eyes and writhing reaction do not occur; after administration, no obvious abnormality occurs in food intake, water intake, defecation and the like. No animals died during the observation period and the weight gain was recorded in table 3. After 14 days of administration, mice are killed by dislocation of cervical vertebrae, and pathological examination is carried out on important visceral organs such as heart, liver, spleen, lung, kidney, uterus, testis, stomach, intestine and the like, and no obvious pathological changes such as hemorrhage, congestion, edema, exudation, ulcer, perforation, no effusion and the like are found in the thoracic cavity, abdominal cavity and pericardium. The results show that the maximum oral tolerance of the mucopolysaccharide powder male and female amphoterics is more than 12 g/kg-1. According to the acute toxicity classification, the sample belongs to the non-toxic grade.
2. Mouse bone marrow cell chromosome aberration test
50 healthy ICR mice of 25-30g were selected and randomly divided into 5 groups of 10 mice each with half of males and females. The prepared samples were divided into 1.0, 2.0, 4.0 g.kg-1The positive control group of three dose groups was treated with Cyclophosphamide (CP)40 mg/kg-1And preparing the mixture to the required concentration by using distilled water. The solvent control group is administered with distilled water for 3 times at an interval of 24 hr, the material is taken 24 hr after the last administration, and the dose is 4 mg/kg 2 hr before killing the animal-1Colchicine is injected into the abdominal cavity of the body weight. Mice are dislocated to sacrifice the cervical vertebra, femurs are taken, bone marrow is washed into a 10ml centrifuge tube, and after repeated washing for a plurality of times, 1.0ml cell suspension is prepared by uniformly mixing the materials by a suction tube. After staining, metaphase chromosome analysis was performed with an oil lens, and 100 metaphase cells were analyzed per animal.
TABLE 4 mouse bone marrow cell chromosomal aberration test results
As can be seen from Table 4, the samples of each dose group have no significant difference compared with the negative control group, have larger difference with the positive control group (CP group), and the chromosome aberration rate of each test result has no dose response relationship. The sample is shown to have no effect of causing chromosome aberration of mouse bone marrow cells.
3. Mouse teratospermia test
Male cleaning grade ICR mice 25, 28-35g weight, randomly divided into 5 groups of 5 mice each. The dosage is 1.0, 2.0, 4.0 g/kg-1Three groups were separately provided with a negative control group and a CP positive control group (50 mg. kg)-1) The test substance was administered by gavage for 5 days continuously until 35d after the test substance was administered for the first time, the mice were sacrificed by cervical dislocation, and the epididymis on both sides was taken out and placed in a dish containing 2ml of physiological saline. Cutting the epididymis longitudinally with an ophthalmic scissors for 1-2 times, standing for 3-5min, and gently shaking. Filtering with synthetic fiber blood bag, sucking filtrate and smearing. Air drying, fixing with methanol for more than 5min, drying, dyeing with 1.5% eosin for 1 hr, rinsing with water, and drying. Each group counted 5 animals and 1000 animals eachThe incidence of aberrant spermatozoa (in percent) was calculated for each structurally intact sperm.
TABLE 5 results of teratospermia test
As can be seen from Table 5, the sample dose groups showed no significant difference from the negative control group, the difference from the positive control group (CP group) was large, and the chromosome aberration rate of each test result showed no dose-response relationship. The sample has no aberration on mouse sperm under the experimental condition.
4.30d feeding test
Clean grade ICR mice 80, weight 18-24g, randomly divided into 4 groups of 20 each, each male and female. The experimental components are 1.0, 2.0 and 4.0 g/kg-1Three dose groups of equal height, medium and low dose. And (5) setting one control group, and performing intragastric administration on the same dose of distilled water every day. The general state, signs, food intake, water intake and fecal status of the mice were observed daily during the experiment. The body weight was measured every 7 days, and the dose was adjusted according to the change in body weight and continuously observed for 30 days. After administration period of 30 days, after fasting and water deprivation for 12h, taking blood from eyeball, and examining hematology index and blood biochemistry index. Immediately after blood collection, organs such as the liver, kidney, spleen, stomach, testis or ovary of the animal are dissected and weighed, the organ weight coefficient is calculated according to the body weight, and the morphological change is observed by naked eyes.
4.1 general toxic reaction
Mice of the high, medium and low dose administration groups and the control group all move normally within a test period of 30d, have lively behaviors, bright hair color, normal eating and drinking, and do not change abnormally in urination or urination, and die.
4.2 results of body weight measurement
As can be seen from Table 6, the weight gain of the high, medium and low dose groups was normal, and no significant difference was observed between the results of the groups compared with the control group (P > 0.05).
Note: significant difference from the control group (P <0.05) and significant difference from the control group (P <0.01)
4.3 measurement results of organ coefficients of mouse
As can be seen from table 7, no significant difference in organ coefficients was observed between the dose groups and the control group after 30d administration ((P > 0.05).
Note: significant difference from the control group (P <0.05) and significant difference from the control group (P <0.01)
4.4 blood general index measurement results
As can be seen from tables 8, 9 and 10, the mouse white blood cell count (WBC), red blood cell count (RBC), hemoglobin concentration (HB), Hematocrit (HCT), mean hematocrit (MCV), Mean Platelet Volume (MPV), mean hemoglobin content (MCH), neutrophil percentage (NE), lymphocyte percentage (LY), eosinophil percentage (EO), monocyte percentage (MO), Basophil (BA), mean hemoglobin concentration (MCHC), red blood cell distribution width (RDW), platelet count (PLT), and the like in each dose group were not significantly different from those in the control group (P > 0.05).
Note: significant difference from the control group (P <0.05) and significant difference from the control group (P <0.01)
4.5 blood Biochemical index measurement results
As can be seen from tables 11 and 12, the blood biochemical indexes such as mouse Triglyceride (TG), total Cholesterol (CHO), glutamic-oxaloacetic transaminase (GOT), glutamic-pyruvic transaminase (GPT), Creatinine (CRE), urea nitrogen (BUN), Glucose (GLU), Total Protein (TP), Albumin (ALB) and the like of each dose group have no significance compared with the control group (P is more than 0.05).
4.630 d histopathological examination of mice fed
The sizes, shapes, colors, textures and the like of organs such as heart, liver, kidney, spleen, stomach, testis, ovary and the like of each group are observed comprehensively and carefully without abnormity. All major organs have no obvious degeneration and necrosis and normal luster.
Claims (9)
1. A preparation method of a microbial flocculant for clarifying brewed vinegar is characterized by comprising the following steps:
1) inoculating Paenibacillus chestnuts to a test tube slant culture medium for activation, washing with sterile water after activation to obtain bacterial suspension, inoculating to a triangular flask containing a seed culture solution for seed culture, and performing microscopic examination to obtain no mixed bacteria for later use;
2) putting the fermentation medium into a fermentation tank, carrying out autoclaving at 121 ℃ for 20 minutes, then inoculating the seeds obtained in the step 1), and carrying out fermentation culture to obtain a culture solution;
3) extracting and purifying the culture solution obtained in the step 2) to obtain the microbial flocculant.
2. The method of claim 1, wherein the slant culture medium in step 1) comprises: 2.0% of soluble starch, 0.5% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate, 0.05% of magnesium sulfate and 2.0% of agar, and the activation culture method comprises the following steps: adjusting pH to 7.0, autoclaving test tube with slant culture medium at 121 deg.C for 20 min, inoculating Paenibacillus chestnut, and culturing at 28 deg.C for 48 hr.
3. The method according to claim 1, wherein the seed culture solution in step 1) is composed of: 1.0% of soluble starch, 1.5% of sucrose, 0.5% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate and 0.05% of magnesium sulfate, and the seed culture method comprises the following steps: the triangular flask containing the seed culture solution was autoclaved at 121 ℃ for 20 minutes, and then the bacterial suspension was inoculated and cultured at 28 ℃ for 30 hours.
4. The method according to claim 1, wherein the fermentation medium used in the step 2) comprises: 3.0% of glucose, 0.1% of sodium nitrate, 0.3% of peptone, 0.05% of potassium chloride, 0.1% of dipotassium hydrogen phosphate and 0.05% of magnesium sulfate.
5. The method according to claim 1, wherein the fermentation culture method in step 2) comprises: the culture temperature is 28 ℃, the ventilation rate is 1VVM, the initial pH is 7.0, the initial stirring rotation speed is 300 r/min, the later stirring rotation speed is linked with dissolved oxygen, the lowest dissolved oxygen is controlled to be 20%, the culture time is 36 hours, the OD600 is more than 2.5, 3.0% (W/V) of cane sugar in the total volume of the fermentation liquid is added, the mixture is uniformly stirred, the mixture is placed in a culture dish, the liquid depth is controlled not to exceed 2.5cm, the culture is continued for 24 hours at 26 ℃, until the culture liquid is in a jelly shape, the charging amount of the fermentation tank is 70%, and the inoculation amount is 3.0%.
6. The method according to claim 1, wherein the microbial flocculant comprises mucopolysaccharides as a main component, and glucosamine and uronic acid are contained in the molecular structure.
7. A microbial flocculant obtained by the production process according to any one of claims 1 to 6.
8. Use of a microbial flocculant according to claim 7 for clarifying brewed vinegar.
9. The use according to claim 8, characterized in that the use is in particular: heating brewed edible vinegar to 41.5 deg.C, adding CaCl2To a final concentration of 0.32mM, and then microbial flocculant was added to a final concentration of 3.94 mg/L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011518642.2A CN112522349A (en) | 2020-12-21 | 2020-12-21 | Microbial flocculant for clarifying brewed vinegar and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011518642.2A CN112522349A (en) | 2020-12-21 | 2020-12-21 | Microbial flocculant for clarifying brewed vinegar and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112522349A true CN112522349A (en) | 2021-03-19 |
Family
ID=75002079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011518642.2A Pending CN112522349A (en) | 2020-12-21 | 2020-12-21 | Microbial flocculant for clarifying brewed vinegar and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112522349A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101503709A (en) * | 2009-03-13 | 2009-08-12 | 厦门大学 | Method for preparing bioflocculation by Bacillus licheniformis |
CN102628066A (en) * | 2012-04-17 | 2012-08-08 | 山西大学 | Preparation method and application of microbial flocculant |
CN104726518A (en) * | 2015-04-09 | 2015-06-24 | 哈尔滨工业大学 | Production method for microbial flocculants |
CN106430627A (en) * | 2016-11-23 | 2017-02-22 | 重庆大学 | Preparation method and application of microbial flocculant |
CN109457002A (en) * | 2018-11-29 | 2019-03-12 | 太原市润民环保节能有限公司 | The method and application of microbial flocculant are prepared using bacillus polymyxa |
-
2020
- 2020-12-21 CN CN202011518642.2A patent/CN112522349A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101503709A (en) * | 2009-03-13 | 2009-08-12 | 厦门大学 | Method for preparing bioflocculation by Bacillus licheniformis |
CN102628066A (en) * | 2012-04-17 | 2012-08-08 | 山西大学 | Preparation method and application of microbial flocculant |
CN104726518A (en) * | 2015-04-09 | 2015-06-24 | 哈尔滨工业大学 | Production method for microbial flocculants |
CN106430627A (en) * | 2016-11-23 | 2017-02-22 | 重庆大学 | Preparation method and application of microbial flocculant |
CN109457002A (en) * | 2018-11-29 | 2019-03-12 | 太原市润民环保节能有限公司 | The method and application of microbial flocculant are prepared using bacillus polymyxa |
Non-Patent Citations (4)
Title |
---|
戴德慧;胡伟莲;: "栗树类芽孢杆菌S3胞外粘多糖毒理安全性评价" * |
曹芳等: "巨大芽孢杆菌MBFF6产絮凝剂培养条件的优化及絮凝剂的化学性质", 《浙江大学学报(农业与生命科学版)》 * |
李楠;邓智年;李贤桢;周开英;梁智群;: "微生物絮凝剂在甘蔗糖厂中的应用研究" * |
罗玉琴等: "微生物絮凝剂BN-25的特性及其在甘蔗混合汁澄清工艺中的应用", 《食品工业科技》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104521832B (en) | Cultivation method for fish fries and adult fishes | |
Lavoie et al. | Harvesting microalgae with chitosan | |
CN102134287B (en) | Preparation method for pipelined extraction of sodium hyaluronate through combs | |
CN112522349A (en) | Microbial flocculant for clarifying brewed vinegar and preparation method and application thereof | |
CN110257296A (en) | The cultural method and application thereof of chromium-rich spirulina | |
CN100467061C (en) | Scorpionfish-ink polysaccharide and its preparation | |
CN113773963A (en) | High-density high-yield porphyridium culture method | |
DE2441454B2 (en) | Antilenkemic proteinaceous fraction and its preparation | |
US10745351B2 (en) | Method of producing phycocyanin powder | |
CN109021095B (en) | A kind of high-purity is without fishy smell algae blue pigment and the preparation method and application thereof | |
WO2009035279A1 (en) | Method for coagulating sludge with use of chitosan and chitosan decomposition enzyme and manufacturing method for fertilizer | |
CN107648269B (en) | Method for extracting antibacterial composition from body cavity fluid of stichopus japonicus, composition and application thereof | |
CN105985899A (en) | Osmanthus-aroma honey vinegar and preparation method thereof | |
Priatni et al. | The screening of antidiabetic activity and the cultivation study of local marine microalgae | |
Eljaddi et al. | Ultrafiltration to secure shellfish industrial activities: Culture of microalgae and oyster fertilization | |
CN103027927A (en) | Production process of transfer factor of spleen of laying hen | |
CN106636261A (en) | Cultivation method of mesenchymal stem cell secretin | |
CN106342759B (en) | A kind of clam worm breeding method for close shrimp biological feedstuff | |
KR19990015682A (en) | How to make laver using chitosan | |
CN109292984A (en) | Improver of water quality used for aquiculture and preparation method thereof | |
CN115181671B (en) | Culture method and application of oleaginous microalgae | |
CN109819915B (en) | Preparation method of shellfish seafood purifying agent and purification method of shellfish seafood | |
CN113100129B (en) | Culture medium and culture method for long-term and continuous culture of back mouth insects | |
CN108617561A (en) | A method of it improving pteria martensii and plants core shellfish core-remaining rate and high-quality pearl rate | |
DE2844311C2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210319 |